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Biotechnology processes are the unique feasible way for the
production of some pharmaceutical active principles. Thus,
developments in molecular biology, recombinant techniques,
separation, and purification methods have a primordial
role because of the innovative characteristic and economic
impact in obtaining these new drugs through biotechno-
logical approaches. This special issue compiles a series of
relevant studies on different biotechnological fields and appli-
cations, reporting up-to-date developments on downstream
and upstream biopharmaceuticals.
Summarizing the results reported in the manuscripts
published here, our readersmay find further insights through
a series of fields, from the most fundamental genetic
approaches to the general aspects of biological and biochem-
ical engineering. A complete study proposed by S. Zhang et
al. applied next-generation RNA sequencing and developed a
method to analyse themutation rate of themRNA of Chinese
hamster ovary producing monoclonal antibodies, which are
widely used for the production of biological therapeutics.
Following the concept of monoclonal antibodies, E. Sasso et
al. have presented a research study where they expanded the
availability of monoclonal antibodies interfering with hepati-
tis C infection in hepatocytes. The results of these authors
report an effective sequencing approach for library screening,
demonstrating the successful conversion of recovered clones
to active immunoglobulins.This novel approach allows rapid
and cheap isolation of antibodies for virtually any native
antigen involved in human diseases, for therapeutic and/or
diagnostic applications.
On the other hand, to clone and express 𝛾-polyglutamic
acid (𝛾-PGA) synthetase gene in B. subtilis, B. Lin et al.
have constructed a plasmid, which allowed the recombinant
microorganism the synthesis of 𝛾-PGA into the fermentation
broth. This approach has potential industrial applications
since 𝛾-PGA is a new water-soluble biodegradable anionic
polypeptide and, due to its interesting properties, such as
nontoxicity, edibility, adhesiveness, film forming, and mois-
ture retention capability, it can be a key compound for the
health care industries. Also R. Niu and X. Chen reported a
full-length cDNA, prokaryotic expression, and antimicrobial
activity of cloned haemoglobin (Hb) fromUrechis unicinctus,
a marine spoon worm and economically important seafood.
Their results elucidate the structure and potential function
of Hb, which may help to understand the immune defense
mechanism of invertebrates and to give some new insights
into antimicrobial peptides for drug discovery and disease
control in U. unicinctus aquaculture. Following the same
concept, in “Enhanced and Secretory Expression of Human
Granulocyte Colony Stimulating Factor by Bacillus subtilis
SCK6,” S. Bashir et al. describe a simplified approach for
enhanced expression and secretion of granulocyte colony
stimulating factor (GCSF), a human cytokine, in the culture
supernatant of B. subtilis SCK6 cells. Their results have
shown that after expression and purification the protein has
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a biological activity similar to the commercial preparation
of GCSF. The last two works of this issue are aimed at the
evaluation of stability of biomolecules and their accurate
quantification, respectively. Formulating appropriate storage
conditions for biopharmaceutical proteins is essential for
ensuring their stability and thereby their purity, potency,
and safety over their shelf life. With that in mind B. K.
Chavez et al. employed a model murine IgG3 produced in a
bioreactor and evaluated multiple formulation compositions.
These studies have evaluated the antibody stability in a series
of conditions using an experimental design approach, an
optimized formulation being identified in which the stability
was substantially improved under long-term storage condi-
tions and after multiple freeze/thaw cycles. The last work is
focused on the importance of proteases in the biotechno-
logical and pharmaceutical industries, and, consequently, the
determination of optimum conditions and the development
of a standard protocol are critical during selection of a reliable
method to determine its bioactivity. With that in mind, D. F.
Coeˆlho et al. employed a quality control theory to validate a
modified version of a method proposed in 1947, presenting
a validated protocol that offers a significant improvement,
given that subjective definitions are commonly used in the
literature and this simple mathematical approach makes it
clear and concise.
The quality of the results and protocols compiled in this
issue have caught our interest, and we hope that these will
help researchers and biotechnology-related professionals to
develop more exciting science regarding the improvement
of the human health and the sustainability and safety of the
biotechnological industry.
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